- Title: “Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis”
Journal: Hepatology Communications (2024)
DOI: 10.1097/HC9.0000000000000423
Publications
We've supported our clients and collaborators on a wide range of scientific publications since our founding, demonstrating the breadth of possible uses for our datasets. See below for more detail or contact us with any questions.
Published Manuscripts
- Title: “Data Challenges for Externally Controlled Trials: Viewpoint”
Journal: Journal of Medical Internet Research (2023)
DOI: 10.2196/43484
- Title: “Prognosis and Therapeutic Response Transfer Learning Model for Multiple Myeloma”
Journal: American Society of Hematology (2021)
DOI: 10.1182/blood-2021-152566
- Title: “Derivation and validation of the ED-SAS score for very early prediction of mortality and morbidity with acute pancreatitis: a retrospective observational study”
Journal: BMC Emergency Medicine (2021)
DOI: 10.1186/S12873-021-00410-W
- Title: “Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy”
Journal: Frontiers in Neurology (2020)
DOI: 10.3389/fneur.2020.00186
- Title: “HLA associations with infliximab-induced liver injury”
Journal: Pharmacogenomics J. (2020)
DOI: 10.1038/s41397-020-0159-0
- Title: “Leveraging Human Genetics to Identify Safety Signals Prior to Drug Marketing Approval and Clinical Use”
Journal: Drug Saf. (2020)
DOI: 10.1007/s40264-020-00915-6
- Title: “Are CAR-T therapies living up to their hype? A study using real-world data in two cohorts to determine how well they are actually working in practice compared with bone marrow transplants”
Journal: BMJ Evidence-Based Medicine (2019)
DOI: 10.1136/bmjebm-2019-111226
- Title: “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”
Journal: Drug Saf. (2018)
DOI: 10.1007/s40264-017-0616-0
- Title: “Using Human ‘Experiments of Nature’ to Predict Drug Safety Issues: An Example with PCSK9 Inhibitors”
Journal: Drug Saf. (2017)
DOI: 10.1007/s40264-017-0616-0
- Title: “Accelerating Precision Drug Development and Drug Repurposing by Leveraging Human Genetics”
Journal: Assay Drug Dev Technol. (2017)
DOI: 10.1089/adt.2016.772
Abstracts
- Title: “Patatin-like phospholipase domain-containing 3 (PNPLA3) risk allele increases rate of progression to end-stage liver disease outcomes and decreases survival rate over time in biopsy confirmed non-alcoholic steatohepatitis patients”
Meeting: EASL 2023
Poster: View Poster Presentation
- Title: “Characterization of an Electronic Health Records Based Charcot Marie Tooth Cohort”
Meeting: Advances in Pain 2022 – Poster presentation
- Title: “The relationship between liver histology and long-term clinical outcomes in patients with non-alcoholic steatohepatitis: a real-world cohort study”
Meeting: AASLD – The Liver Meeting 2022
- Title: “Clinical Outcomes Of Solid Organ Transplant Patients With Epstein-Barr Virus-Driven (Ebv+) Post-Transplant Lymphoproliferative Disorder (Ptld) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study”
Meeting: Congress of the French Society of Hematology 2022
- Title: “Clinical Outcomes Of Solid Organ Transplant Patients With Epstein-Barr Virus-Driven (Ebv+) Post-Transplant Lymphoproliferative Disorder (Ptld) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study”
Meeting: American Society of Hematology 2022
- Title: “Clinical Outcomes Of Solid Organ Transplant (SOT) Patients With Epstein–Barr Virus-Driven (EBV+) Post-Transplant Lymphoproliferative Disease (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study.”
Meeting: American Transplant Congress 2022
- Title: “The Kidney Genome Atlas – a resource to understand APOL1 and other genetic drivers of adult proteinuric kidney diseases”
Meeting: ASN 2021
- Title: “The Kidney Genome Atlas reveals a novel locus on chromosome 14 associated with adult proteinuric kidney diseases”
Meeting: ASHG 2021
- Title: “Unraveling the genetic contribution of kidney disease with the Kidney Genome Atlas”
Meeting: ASN 2019
- Title: “Kidney Genome Atlas: a whole-genome landscape of more than 2,500 kidney disease patients”
Meeting: ISN WSN 2019
- Title: “The Kidney Genome Atlas: a comprehensive whole genome and transcriptome landscape of proteinuric kidney diseases”
Meeting: Keystone Symposium 2019
- Title: “Mitigating batch effects in >23,000 WGS samples for a case-control GWAS of kidney disease”
Meeting: ASHG 2019
- Title: “Kidney Genome Atlas (KGA): a whole-genome landscape of more than 2,000 kidney disease patients”
Meeting: ASHG 2018
Data Solutions with
Your Goals in Mind
Let us help you get the exact data you need so you can advance novel discoveries, streamline operations and increase speed to market.
